Explore the future of Bioprocess with MilliporeSigma. Be sure to join our sessions to learn more about: 

• Reducing steps and increasing throughput for your seed train
• Insights on the path from research to commercialization for Gene Therapy
• Biopharma industry's current AI maturity level and future applications
• Use of advanced analytics in identifying outlier batches

Don't miss our technical posters featured in the program:

• Strategies for Clarifying Harvest Feed Streams in Viral Vector Bioprocessing
• Novel Rapid Molecular Technologies for Biosafety Testing

Be sure to visit our showcase pages: 

• Bioprocessing 4.0 to learn more about how we can converge, intensify and evolve together
• Cell and Gene Therapy to see how you can draw on our experience to bring your gene therapy to life

MilliporeSigma, a life science leader, is a business of Merck KGaA, Darmstadt, Germany.